Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-84P (RNA, U6 small nuclear 84, pseudogene) is a genomic pseudogene derived from the U6 small nuclear RNA gene. Pseudogenes like RNU6-84P do not code for functional RNA or protein but instead represent non-functional genomic relics, typically arising from gene duplication or retrotransposition events involving processing of snRNA genes such as U6. The functional U6 small nuclear RNA (U6 snRNA), of which RNU6-84P is a non-functional copy, is an essential, highly conserved non-coding RNA that participates in the spliceosome, the large RNA-protein complex catalyzing intron excision from pre-mRNA in eukaryotes. However, RNU6-84P itself has no known biological activity, is not a protein, and is not considered a therapeutic target. There are no known drugs, biomarkers, or established disease links associated with RNU6-84P. Key contextual details: - The presence of many U6 snRNA pseudogenes is typical in vertebrates and reflects evolutionary genomic duplication and retrotransposition events. - While some pseudogenes can have regulatory roles (e.g., by acting as competitive endogenous RNAs), no such function or disease association is known for RNU6-84P. - RNU6-84P should not be confused with the functional U6 snRNA, which is critical for RNA splicing and cell viability. Summary judgment: RNU6-84P is a non-functional pseudogene and not a true molecular target, not involved in disease, drug action, or therapy. Any functional or disease-relevant information about U6 snRNA does not apply to RNU6-84P itself.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 84, pseudogene (RNU6-84P).